Global Gastrointestinal Stent
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Gastrointestinal Stent market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Gastrointestinal Stent market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Type Outlook: Segment Analysis | Esophageal Stents, Duodenal Stents, Colonic Stents, Biliary/Pancreatic Stents |
| Stent Type Outlook: Segment Analysis | Metal Stents (Self-Expanding Metal Stents, Nitinol, Stainless steel, Other metal stents), Plastic Stents, Biodegradable/Drug Eluting Stents |
| Application Outlook: Segment Analysis | Gastrointestinal Obstructions, Colorectal Cancer, Inflammatory Bowel Disease, Biliary Diseases, Irritable Bowel Syndrome, Gastrointestinal Cancers (Colorectal cancer, Stomach cancer, Esophageal cancer, and Pancreatic cancer), Others (GI Bleeding, Gastric Cardia Cancer, etc.) |
|---|---|
| End User Outlook: Segment Analysis | Hospitals and Clinics, Ambulatory Surgical Centers, Specialty Centers |
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Gastrointestinal Stent Market Report 2025.
According to Cognitive Market Research, the global Gastrointestinal Stents market size will be USD 478.8 million in 2025. It will expand at a compound annual growth rate (CAGR) of 6.20% from 2025 to 2033.
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Gastrointestinal Stent Market Sales Revenue | xxxx | $ 478.8 Million | $ 774.72 Million | 6.2% |
| North America Gastrointestinal Stent Market Sales Revenue | xxxx | $ 177.16 Million | $ 242.5 Million | 4% |
| United States Gastrointestinal Stent Market Sales Revenue | xxxx | $ 139.78 Million | xxxx | 3.8% |
| Canada Gastrointestinal Stent Market Sales Revenue | xxxx | $ 21.26 Million | xxxx | 4.8% |
| Mexico Gastrointestinal Stent Market Sales Revenue | xxxx | $ 16.12 Million | xxxx | 4.5% |
| Europe Gastrointestinal Stent Market Sales Revenue | xxxx | $ 138.85 Million | $ 197.5 Million | 4.5% |
| United Kingdom Gastrointestinal Stent Market Sales Revenue | xxxx | $ 23.33 Million | xxxx | 5.3% |
| France Gastrointestinal Stent Market Sales Revenue | xxxx | $ 12.77 Million | xxxx | 3.7% |
| Germany Gastrointestinal Stent Market Sales Revenue | xxxx | $ 27.49 Million | xxxx | 4.7% |
| Italy Gastrointestinal Stent Market Sales Revenue | xxxx | $ 11.94 Million | xxxx | 3.9% |
| Russia Gastrointestinal Stent Market Sales Revenue | xxxx | $ 21.52 Million | xxxx | 3.5% |
| Spain Gastrointestinal Stent Market Sales Revenue | xxxx | $ 11.39 Million | xxxx | 3.6% |
| Sweden Gastrointestinal Stent Market Sales Revenue | xxxx | $ 4.3 Million | xxxx | 4.6% |
| Denmark Gastrointestinal Stent Market Sales Revenue | xxxx | $ 2.92 Million | xxxx | 4.3% |
| Switzerland Gastrointestinal Stent Market Sales Revenue | xxxx | $ 2.08 Million | xxxx | 4.2% |
| Luxembourg Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.67 Million | xxxx | 4.8% |
| Rest of Europe Gastrointestinal Stent Market Sales Revenue | xxxx | $ 19.44 Million | xxxx | 3.2% |
| Asia Pacific Gastrointestinal Stent Market Sales Revenue | xxxx | $ 114.91 Million | $ 215.9 Million | 8.2% |
| China Gastrointestinal Stent Market Sales Revenue | xxxx | $ 48.26 Million | xxxx | 7.7% |
| Japan Gastrointestinal Stent Market Sales Revenue | xxxx | $ 15.86 Million | xxxx | 6.7% |
| South Korea Gastrointestinal Stent Market Sales Revenue | xxxx | $ 13.79 Million | xxxx | 7.3% |
| India Gastrointestinal Stent Market Sales Revenue | xxxx | $ 11.49 Million | xxxx | 10.1% |
| Australia Gastrointestinal Stent Market Sales Revenue | xxxx | $ 5.98 Million | xxxx | 7.5% |
| Singapore Gastrointestinal Stent Market Sales Revenue | xxxx | $ 2.3 Million | xxxx | 8.5% |
| Taiwan Gastrointestinal Stent Market Sales Revenue | xxxx | $ 4.48 Million | xxxx | 8% |
| South East Asia Gastrointestinal Stent Market Sales Revenue | xxxx | $ 7.58 Million | xxxx | 9% |
| Rest of APAC Gastrointestinal Stent Market Sales Revenue | xxxx | $ 5.17 Million | xxxx | 8% |
| South America Gastrointestinal Stent Market Sales Revenue | xxxx | $ 18.19 Million | $ 27.3 Million | 5.2% |
| Brazil Gastrointestinal Stent Market Sales Revenue | xxxx | $ 7.79 Million | xxxx | 5.8% |
| Argentina Gastrointestinal Stent Market Sales Revenue | xxxx | $ 3.06 Million | xxxx | 6.1% |
| Colombia Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.62 Million | xxxx | 5% |
| Peru Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.49 Million | xxxx | 5.4% |
| Chile Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.31 Million | xxxx | 5.5% |
| Rest of South America Gastrointestinal Stent Market Sales Revenue | xxxx | $ 2.93 Million | xxxx | 4.3% |
| Middle East Gastrointestinal Stent Market Sales Revenue | xxxx | $ 19.15 Million | $ 29.4 Million | 5.5% |
| Qatar Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.53 Million | xxxx | 5% |
| Saudi Arabia Gastrointestinal Stent Market Sales Revenue | xxxx | $ 6.74 Million | xxxx | 5.8% |
| Turkey Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.53 Million | xxxx | 6.1% |
| UAE Gastrointestinal Stent Market Sales Revenue | xxxx | $ 3.95 Million | xxxx | 6% |
| Egypt Gastrointestinal Stent Market Sales Revenue | xxxx | $ 1.15 Million | xxxx | 5.3% |
| Rest of Middle East Gastrointestinal Stent Market Sales Revenue | xxxx | $ 4.25 Million | xxxx | 4.7% |
| Africa Gastrointestinal Stent Market Sales Revenue | xxxx | $ 10.53 Million | $ 16.7 Million | 5.9% |
| Nigeria Gastrointestinal Stent Market Sales Revenue | xxxx | $ 0.84 Million | xxxx | 6.1% |
| South Africa Gastrointestinal Stent Market Sales Revenue | xxxx | $ 3.71 Million | xxxx | 6.8% |
Gastrointestinal Stent Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The gastrointestinal stents market plays a vital role in modern gastroenterology by offering minimally invasive solutions for managing obstructions and strictures in the digestive tract. These stents are primarily used to treat conditions such as colorectal cancer, oesophagal cancer, biliary obstructions, and other benign or malignant gastrointestinal disorders. Designed to keep passageways open, gastrointestinal stents improve patients' quality of life by restoring normal digestive function and reducing the need for invasive surgeries. The market is driven by a growing global prevalence of gastrointestinal cancers, an ageing population, and increased adoption of endoscopic procedures. Technological advancements, including the development of self-expanding metallic stents and biodegradable materials, continue to enhance performance, reduce complications, and expand clinical applications.
In February 2023, Olympus Corporation announced the acquisition of Taewoong Medical Co., Ltd, a manufacturer of medical devices, including gastrointestinal (GI) metallic stents, among others. This acquisition helped the company expand its GI EndoTherapy product portfolio, enhance its R&D capabilities, and increase business revenue. https://www.olympus-global.com/news/2024/nr02610.html
The primary drivers of the gastrointestinal (GI) stents market are the increasing incidence of gastrointestinal diseases, such as colorectal cancer, oesophagal cancer, inflammatory bowel disease (IBD), and other chronic GI conditions. The growing elderly population, who are more prone to GI complications, further fuels this trend. According to global cancer statistics, colorectal and gastric cancers rank among the top causes of cancer-related deaths, which necessitates effective palliative treatment solutions, such as stenting, for managing obstructions. Stents offer a minimally invasive method to relieve blockages, significantly improving the quality of life for patients with malignancies. Moreover, lifestyle changes like poor dietary habits, high alcohol consumption, and smoking are contributing to the rise in GI ailments. For instance, Boston Scientific Corporation announced a strategic agreement with Synergy Innovation Co., Ltd to acquire a majority shares of M.I.Tech Co., Ltd. This company is a manufacturer of HANAROSTENT technology, providing conformable, non-vascular, self-expanding metal stents. This strategic move helped the company integrate advanced technologies into its business, enhance its customer base, and gain a competitive edge over its peers.
Modern GI stents are now more efficient, with features like anti-migration design, biodegradable materials, drug-eluting properties, and improved radial force, enhancing patient outcomes and minimizing complications. These innovations are particularly beneficial in treating complex obstructions or strictures, offering higher safety and effectiveness. Additionally, improvements in imaging and endoscopic technologies have increased the precision of stent placement, reducing procedure-related risks and enhancing recovery times. The integration of biodegradable and drug-eluting stents is opening new avenues for temporary support without the need for removal procedures, thereby minimizing patient discomfort. These technological advancements are attracting attention from both healthcare providers and patients seeking less invasive, more comfortable treatment options.
The high cost associated with gastrointestinal stent procedures and devices significantly restrains market growth, particularly in low- and middle-income countries. Gastrointestinal stents, whether self-expanding metal stents (SEMS) or plastic stents are costly to manufacture due to the materials used and the complex engineering required to ensure safety and efficacy. In addition, endoscopic placement procedures require skilled healthcare professionals and advanced imaging technologies, further adding to the overall cost burden. These high expenses make the procedures less accessible to patients without comprehensive health insurance or those living in regions with underdeveloped healthcare infrastructure. This economic barrier often leads to delayed diagnosis and treatment or a preference for alternative, more affordable therapeutic options.
The shift toward minimally invasive surgeries (MIS) is significantly influencing the gastrointestinal stents market. Patients and healthcare providers increasingly prefer endoscopic stent placements over open surgical interventions due to lower complication risks, reduced hospital stays, and faster recovery times. Gastrointestinal stents offer a less traumatic alternative for managing obstructions in the biliary tract, colon, or oesophagus caused by malignant or benign diseases. This trend is further supported by advances in imaging and endoscopic technologies, making stent placements more precise and effective. Moreover, the growing geriatric population, which is more vulnerable to gastrointestinal conditions, is accelerating demand for these safer, less invasive options. As a result, companies are innovating stent designs that ensure better biocompatibility, flexibility, and long-term patency, thereby enhancing procedural success and patient outcomes.
The gastrointestinal stents market is witnessing rapid innovation in terms of design and material composition. Traditional stents have evolved to include fully covered, partially covered, and drug-eluting variants tailored for specific anatomical regions and clinical conditions. Manufacturers are increasingly focusing on developing biodegradable stents that reduce the need for removal procedures and lower the risk of long-term complications such as migration or tissue in-growth. Additionally, improvements in self-expanding metallic stents (SEMS) have enhanced flexibility, radial force, and patient comfort. The integration of advanced imaging modalities and smart coatings that respond to physiological cues is also on the rise, allowing for more precise deployment and prolonged therapeutic efficacy. These advancements not only improve the safety and effectiveness of stenting procedures but also align with the demand for patient-centric solutions.
We have various report editions of Gastrointestinal Stent Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The gastrointestinal stents market is highly competitive, with key players focusing on innovation, product expansion, and strategic partnerships. These firms invest heavily in research and development to enhance stent design, materials, and drug-eluting technologies. Regional players are also emerging, offering cost-effective alternatives, thereby intensifying competition and expanding global market reach.
Top Companies Market Share in Gastrointestinal Stent Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Boston Scientific Corporation | xxxx | xxxx | xxxx | xxxx |
| Cantel Medical | xxxx | xxxx | xxxx | xxxx |
| Conmed Corporation | xxxx | xxxx | xxxx | xxxx |
| Cook Medical | xxxx | xxxx | xxxx | xxxx |
| ELLA-CS | xxxx | xxxx | xxxx | xxxx |
| s.r.o. | xxxx | xxxx | xxxx | xxxx |
| Gore Medical | xxxx | xxxx | xxxx | xxxx |
| Hobbs Medical | xxxx | xxxx | xxxx | xxxx |
| Medtronic plc | xxxx | xxxx | xxxx | xxxx |
| Micro-Tech (Nanjing) Co | xxxx | xxxx | xxxx | xxxx |
| Olympus America | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Gastrointestinal Stents market, and the region is expected to have significant growth during the projected period. This growth is due to its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of key market players. The region benefits from increased awareness of gastrointestinal diseases, high healthcare spending, and the widespread availability of technologically advanced stents. Additionally, a growing elderly population and rising incidence of gastrointestinal cancers further contribute to the region's leading position in the global market.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This growth is due to its rapidly ageing population, rising incidence of gastrointestinal cancers, and increasing adoption of minimally invasive procedures. Expanding healthcare infrastructure, growing medical tourism, and improving access to advanced diagnostics and treatments further support market growth.
The current report Scope analyzes Gastrointestinal Stent Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Gastrointestinal Stents market size was estimated at USD 43521.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 177.16 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Gastrointestinal Stents market with a market size of USD 139.78 million in 2025 and is projected to grow at a CAGR of 3.8% during the forecast period due to the advanced healthcare infrastructure.
The Canadian Gastrointestinal Stents market had a market share of USD 21.26 million in 2025 and is projected to grow at a CAGR of 4.8% during the forecast period due to rising geriatric population prone to gastrointestinal obstructions and complications.
The Mexico Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 16.12 million in 2025..
According to Cognitive Market Research, the global Gastrointestinal Stents market size was estimated at USD 478.8 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 138.85 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2033.
The United Kingdom Gastrointestinal Stents market had a market share of USD 23.33 million in 2025 and is projected to grow at a CAGR of 5.3% during the forecast period. In the UK, Gastrointestinal stent sales witnessed an upswing due to advancements in stent design and materials .
The France Gastrointestinal Stents market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 12.77 million in 2025.
According to Cognitive Market Research, the German Gastrointestinal Stents market size was valued at USD 27.49 million in 2025 and is projected to grow at a CAGR of 4.7% during the forecast period due to expanding healthcare infrastructure and reimbursement
The Italy Gastrointestinal Stents market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 11.94 million in 2025.
The Russian gastrointestinal Stents market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 21.52 million in 2025
The Spain Gastrointestinal Stents market is projected to witness growth at a CAGR of 3.6% during the forecast period with a market size of USD 11.39 million in 2025
The Sweden Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 4.30 million in 2025.
The Denmark Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 2.92 million in 2025
The Switzerland Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 2.08 million in 2025.
The Luxembourg Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 1.67 million in 2025.
The Rest of Europe's Gastrointestinal Stents market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 19.44 million in 2025.
According to Cognitive Market Research, the global Gastrointestinal Stents market size was estimated at USD 478.8 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 114.91 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2033.
According to Cognitive Market Research, the China Gastrointestinal Stents market size was valued at USD 48.26 million in 2025 and is projected to grow at a CAGR of 7.7% during the forecast period. Gastrointestinal Stents surged in China due to the growing elderly population.
The Japan Gastrointestinal Stents market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 15.86 million in 2025
The South Korean gastrointestinal Stents market had a market share of USD 13.79 million in 2025 and is projected to grow at a CAGR of 7.3% during the forecast period due to expanding healthcare infrastructure and accessibility.
The Indian Gastrointestinal Stents market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 11.49 million in 2025.
The Australian Gastrointestinal Stents market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 5.98 million in 2025.
The Singapore Gastrointestinal Stents market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 2.30 million in 2025.
The Taiwan Gastrointestinal Stents market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 4.48 million in 2025.
The South East Asia Gastrointestinal Stents market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 7.58 million in 2025.
The Rest of APAC Gastrointestinal Stents market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 5.17 million in 2025.
According to Cognitive Market Research, the global Gastrointestinal Stents market size was estimated at USD 478.8 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 18.19 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Gastrointestinal Stents market size was valued at USD 7.79 million in 2025 and is projected to grow at a CAGR of 5.8% during the forecast period. Gastrointestinal Stents flourished in Brazil due to growing geriatric population prone to gastrointestinal disorders.
Argentina's Gastrointestinal Stents market had a market share of USD 3.06 million in 2025 and is projected to grow at a CAGR of 6.1% during the forecast period due to expanding access to healthcare services and improved diagnostic capabilities.
Colombia Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 1.62 million in 2025
Peru Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 1.49 million in 2025.
Chile Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 1.31 million in 2025
The Rest of South America's Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 2.93 million in 2025.
According to Cognitive Market Research, the global Gastrointestinal Stents market size was estimated at USD 478.8 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 19.15 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2033..
The Qatar Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 1.53 million in 2025. Gastrointestinal Stent sales flourish due to the growing geriatric population.
The Saudi Arabia Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 6.74 million in 2025.
The Turkey Gastrointestinal Stents market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 1.53 million in 2025. Gastrointestinal Stents sales flourished in Turkey due to the expansion of healthcare infrastructure and access to advanced endoscopic procedures.
The UAE Gastrointestinal Stents market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 3.95 million in 2025.
The Egypt Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 1.15 million in 2025.
The Rest of the Middle East Gastrointestinal Stents market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 4.25 million in 2025
According to Cognitive Market Research, the global Gastrointestinal Stents market size was estimated at USD 478.8 Million, out of which Africa held the major market share of around 2% of the global revenue with a market size of USD 10.53 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2033..
The Nigeria Gastrointestinal Stents market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 0.84 million in 2025. Gastrointestinal Stent sales flourish due to the improving healthcare infrastructure.
The South Africa Gastrointestinal Stents market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 3.71 million in 2025.
The Rest of Africa's Gastrointestinal Stents market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 5.98 million in 2025.
Conclusion
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Gastrointestinal Stent Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Gastrointestinal Stent Industry growth. Gastrointestinal Stent market has been segmented with the help of its Product Type Outlook:, Stent Type Outlook: Application Outlook:, and others. Gastrointestinal Stent market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Gastrointestinal Stents Market?
According to Cognitive Market Research, Biliary/Pancreatic Stents are likely to dominate the Gastrointestinal Stents Market. This is due to the high prevalence of biliary and pancreatic cancers and related obstructions. These stents are essential for relieving ductal blockages caused by tumours or gallstones, making them a critical component in palliative care. Their widespread use in endoscopic retrograde cholangiopancreatography (ERCP) procedures and continuous innovations in stent design further reinforce their leading market position.
Colonic Stents are the fastest-growing segment in the Gastrointestinal Stents Market. This growth is due to the increasing incidence of colorectal cancer and bowel obstructions. These stents offer a minimally invasive alternative to emergency surgeries, leading to reduced morbidity and improved patient outcomes. Technological advancements, such as self-expanding metal stents (SEMS), have enhanced performance and durability, further driving adoption. Additionally, the growing preference for minimally invasive procedures among patients and healthcare providers contributes to the accelerated demand for colonic stents.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Gastrointestinal Stent Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the metal stents segment holds the largest share of the market. This is due to their superior flexibility, radial strength, and longer patency compared to plastic alternatives. They are widely used in treating malignant obstructions in the oesophagus, colon, and biliary tract. Their durability, reduced risk of migration, and improved patient outcomes make them the preferred choice among healthcare professionals, driving their continued dominance in the global market.
In the Gastrointestinal Stents Market, the biodegradable/drug-eluting stents segment has been expanding at a rapid pace. This growth is due to their enhanced therapeutic benefits and reduced complication risks. Biodegradable stents eliminate the need for removal procedures while drug-eluting variants prevent tissue in-growth and restenosis by delivering localized medication. These innovations improve patient outcomes, lower recurrence rates, and align with the growing demand for advanced, minimally invasive, and patient-friendly treatment options in gastrointestinal care.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the colorectal cancer segment holds the largest market share due to its high global prevalence and frequent association with bowel obstructions. Stents offer an effective, minimally invasive palliative treatment to relieve blockages and improve patient comfort, especially in advanced-stage cases. The growing incidence of colorectal cancer, particularly among ageing populations, drives the demand for colorectal stenting, making it a major segment within the gastrointestinal stent market.
In the Gastrointestinal Stents market, the rapidly growing sector is the gastrointestinal cancers category due to their rising global prevalence, particularly colorectal, oesophagal, and pancreatic cancers. These malignancies often lead to obstruction, requiring stent placement to relieve symptoms and improve quality of life. The increasing ageing population, early cancer detection, and preference for palliative, minimally invasive treatments are accelerating the demand for gastrointestinal stents in managing these complex cancer cases.
According to Cognitive Market Research, the hospitals and clinics segment holds the largest market share due to their advanced infrastructure, skilled medical professionals, and high patient footfall for diagnostic and therapeutic procedures. These facilities are primary centres for endoscopic interventions, making them key users of stents. Additionally, the availability of specialized gastroenterology departments and integration with surgical units enable timely and effective stent placements, driving demand and reinforcing their leading position in the market.
In the Gastrointestinal Stents market, the rapidly growing sector is the ambulatory surgical centres category due to several factors. Patients increasingly prefer ASCs for stent procedures because they offer cost-effective treatments, shorter stays, and reduced infection risks compared to hospitals. ASCs provide flexible scheduling and a more comfortable environment, enhancing patient satisfaction. Additionally, advancements in minimally invasive techniques have made complex procedures feasible in outpatient settings.
Disclaimer:
| Product Type Outlook: | Esophageal Stents, Duodenal Stents, Colonic Stents, Biliary/Pancreatic Stents |
| Stent Type Outlook: | Metal Stents (Self-Expanding Metal Stents, Nitinol, Stainless steel, Other metal stents), Plastic Stents, Biodegradable/Drug Eluting Stents |
| Application Outlook: | Gastrointestinal Obstructions, Colorectal Cancer, Inflammatory Bowel Disease, Biliary Diseases, Irritable Bowel Syndrome, Gastrointestinal Cancers (Colorectal cancer, Stomach cancer, Esophageal cancer, and Pancreatic cancer), Others (GI Bleeding, Gastric Cardia Cancer, etc.) |
| End User Outlook: | Hospitals and Clinics, Ambulatory Surgical Centers, Specialty Centers |
| List of Competitors | Boston Scientific Corporation, Cantel Medical, Conmed Corporation, Cook Medical, ELLA-CS, s.r.o., Gore Medical, Hobbs Medical, Medtronic plc, Micro-Tech (Nanjing) Co, Olympus America |
Chapter 1 2026 Geopolitical Outlook - Gastrointestinal Stent Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review Global Gastrointestinal Stent Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review North America Gastrointestinal Stent Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review Europe Gastrointestinal Stent Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review Asia Pacific Gastrointestinal Stent Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review South America Gastrointestinal Stent Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review Middle East Gastrointestinal Stent Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Gastrointestinal Stent. Further deep in this chapter, you will be able to review Middle East Gastrointestinal Stent Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Gastrointestinal Stent. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Type Outlook: Analysis 2019 -2031, will provide market size split by Product Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Type Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Stent Type Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Application Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 15 Market Split by End User Outlook: Analysis 2022 - 2034
Chapter 16 Gastrointestinal Stent Price Trend Analysis
Chapter 17 Gastrointestinal Stent Import/Export Analysis
Chapter 18 Gastrointestinal Stent Production Analysis
Chapter 19 Gap Analysis
Chapter 20 Strategy Analysis
Chapter 21 Profitability and Gross Margin Analysis
Chapter 22 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Gastrointestinal Stent market
Chapter 23 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 24 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.